Expanded recall follows the firm’s initial recall of Avastin.
L’Agenzia Italiana del Farmaco rende disponibili on line nuove ed importanti informazioni sull'incremento del tasso di rigetto acuto osservato con Nulojix® (belatacept) in associazione con una riduzione rapida del dosaggio dei corticosteroidi nei pazienti ad alto rischio immunologico per rigetto acuto.
Clinical Specialties received reports of five intra-ocular infections from physician’s office.
L’Agenzia Italiana del Farmaco rende disponibili on line nuove ed importanti
informazioni sulla sicurezza del medicinale Mimpara (cinacalcet).
Administration of an intravenous product found to be contaminated with mold could result in a fatal infection in a broad array of patients.
May permit solutions to flow at a higher rate than intended, and may cause serious adverse health consequences, including death.
Unpublished new findings by a group of academic researchers suggest an increased risk of pancreatitis and pre-cancerous cellular changes called pancreatic duct metaplasia.
80.211.154.110